Literature DB >> 15641399

Evaluation of abnormal liver-enzyme results in asymptomatic patients.

C Verslype1.   

Abstract

Abnormal liver enzymes may be present in the absence of symptoms and signs of liver disease. A good clinical history and physical examination are mandatory. If a systematic approach is adopted, based on additional non-invasive serological tests and imaging procedures covering the most frequent liver diseases, the cause is often apparent. The clinician should be aware of nonhepatic diseases that can cause abnormal liver enzymes, such as thyroid disorders and occult celiac disease. In those patients in which no explanation can be found at the time of the initial evaluation for these abnormal liver enzymes, there is a high probability of non-alcoholic fatty liver disease. The risks and benefits of a liver biopsy in this setting should be carefully considered, as it only seldom alters management.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15641399     DOI: 10.1179/acb.2004.042

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  6 in total

1.  A predictive model for the diagnosis of non-alcoholic fatty liver disease based on an integrated machine learning method.

Authors:  Xuefeng Ma; Chao Yang; Kun Liang; Baokai Sun; Wenwen Jin; Lizhen Chen; Mengzhen Dong; Shousheng Liu; Yongning Xin; Likun Zhuang
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

Review 2.  Endobiogeny: a global approach to systems biology (part 1 of 2).

Authors:  Jean-Claude Lapraz; Kamyar M Hedayat
Journal:  Glob Adv Health Med       Date:  2013-01

Review 3.  Elevated Liver Enzymes in Asymptomatic Patients - What Should I Do?

Authors:  Mazyar Malakouti; Archish Kataria; Sayed K Ali; Steven Schenker
Journal:  J Clin Transl Hepatol       Date:  2017-09-21

4.  AST/ALT ratio as a significant predictor of the incidence risk of prostate cancer.

Authors:  Jiatong Zhou; Zhaowei He; Shenfei Ma; Ranlu Liu
Journal:  Cancer Med       Date:  2020-06-20       Impact factor: 4.452

5.  An Increased Aspartate to Alanine Aminotransferase Ratio Is Associated With a Higher Risk of Cognitive Impairment.

Authors:  Wei Li; Ling Yue; Lin Sun; Shifu Xiao
Journal:  Front Med (Lausanne)       Date:  2022-04-07

6.  New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review.

Authors:  Saad Alhumaid; Abbas Al Mutair; Ali A Rabaan; Fatemah M ALShakhs; Om Prakash Choudhary; Shin Jie Yong; Firzan Nainu; Amjad Khan; Javed Muhammad; Fadil Alhelal; Mohammed Hussain Al Khamees; Hussain Ahmed Alsouaib; Ahmed Salman Al Majhad; Hassan Redha Al-Tarfi; Ali Hussain ALyasin; Yaqoub Yousef Alatiyyah; Ali Ahmed Alsultan; Mohammed Essa Alessa; Mustafa Essa Alessa; Mohammed Ahmed Alissa; Emad Hassan Alsayegh; Hassan N Alshakhs; Haidar Abdullah Al Samaeel; Rugayah Ahmed AlShayeb; Dalal Ahmed Alnami; Hussain Ali Alhassan; Abdulaziz Abdullah Alabdullah; Ayat Hussain Alhmed; Faisal Hussain AlDera; Khalid Hajissa; Jaffar A Al-Tawfiq; Awad Al-Omari
Journal:  BMC Gastroenterol       Date:  2022-10-13       Impact factor: 2.847

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.